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Abstract
The protein hormone insulin exists in several forms in nature, and a large number of modified sequences are used in phar-
macy. They differ by physicochemical properties and efficiency of biological action. Pancreatic bovine insulin was studied 
in an acidic solution by nuclear magnetic resonance spectroscopy. 1 H and 13 C NMR signal assignment of backbone and side 
chains was made by analysis of a set of 2D spectra obtained on a sample with natural isotope abundance. The presence of 
certain secondary structure elements was revealed on a qualitative level based on nuclear Overhauser effect spectroscopy, 
which are similar to those observed in the crystal structure. The C-terminus of the B-chain possessed a remarkable flex-
ibility. The molecule was shown to exist in exchange with oligomers based on its self-diffusion coefficient and correlation 
time measurements performed at different concentrations. Certain signals in the NOESY and HSQC spectra are consistent 
with the presence of minor conformers; this is an obstacle in simulating the molecular structure under the conditions used 
in the experiment.
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Introduction
The family of insulin molecules is known for its role in 
glucose metabolism. Insulin is an irreplaceable supple-
ment for people suffering from diabetes mellitus (DM). It 
is classified into four classes: type 1, type 2, gestational 
DM, and relatively rare cases such as monogenic diabetes 
syndromes (Classification and Diagnosis 2018). Reduced 
expression of insulin and insulin receptors in the brain tissue 
of patients with Alzheimer disease was revealed recently, 
and this state has been called type 3 DM (Leszek et al. 2017). 
Type 1 DM is caused by loss of 훽-cells in pancreas as a result 
of autoimmune reaction, type 2 DM develops due to insulin 
resistance and/or a decrease in insulin secretion. All patients 
with type 1 DM and many suffering from the other types 
have to take insulin injections on a regular basis throughout 
life. Some types of the disease, especially type 2, are treated 
by sulfonylurea; sometimes pramlintide (Ryan et al. 2005), 
metformin (Viollet et al. 2012) or other compounds are used 
as an additional drug, but artificial regulation of the blood 
glucose level by the corresponding hormone—insulin—still 
remains the only existing way of helping people with defi-
cient insulin secretion.
Depending on the type of the disease, general health and 
lifestyle of a patient, different types of insulin preparations 
may be used: rapid-acting, regular, intermediate- and long-
acting variants; methods of intake include use of syringe 
or pen, insulin pump, or less common ways such as inhal-
ing. All these variants lay down certain requirements on the 
molecular properties of insulin preparations which should 
provide the best possible efficiency and safety.
Therefore, investigation of its structure and conforma-
tion changes which accompany binding to other molecules 
(stabilizing additives, receptor, zinc ions…) are of fun-
damental interest. On the other hand, physicochemical 
properties such as solubility and stability are important in 
drug preparation. Insulin therapeutic forms usually require 
the presence of Zn2+ ion, which leads to hexamer forma-
tion (Kadima 1999; O’Donoghue et al. 2000; Palmieri et al. 
2013). Modifying the amino acid sequence which leads to 
longer and more impressive action of the drug is also an 
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